| 产品描述: | SARS-CoV和SARS-CoV-2 PLpro抑制剂;SARS-CoV and SARS-CoV-2 PLpro inhibitor;;PLpro inhibitor (compound 6) is a potent papain-like protease (PLpro)/deubiquitinase (DUBs) inhibitor with IC50 of 2.6 μM and EC50 of 13.1 μM that blocks SARS virus replication. |
| 靶点: |
IC50 : 2.6 µM (Papain-like protease (PLpro)); 5.0 µM (SARS-CoV-2 PLpro);EC50: 21.0 µM (SARS-CoV-2 PLpro) |
| 参考文献: |
1. Ratia, K., et al., A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication. Proc Natl Acad Sci U S A, 2008. 105(42): p. 16119-24. 2. http://www.google.com/patents/WO2010022355A1cl=en3. Brendan T Freitas, et al. Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease. ACS Infect Dis. 2020 May 19. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.887 ml |
14.433 ml |
28.866 ml |
| 5 mM |
0.577 ml |
2.887 ml |
5.773 ml |
| 10 mM |
0.289 ml |
1.443 ml |
2.887 ml |
| 50 mM |
0.058 ml |
0.289 ml |
0.577 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |